Expanded Access Program With Nivolumab to Treat Melanoma

Clinical trial NCT02142218 · NO_LONGER_AVAILABLE

Trial details

NCT number: NCT02142218
Sponsor: Bristol-Myers Squibb
Status: NO_LONGER_AVAILABLE
Study type: EXPANDED_ACCESS

Stage III (Unresectable) or Stage IV Advanced Melanoma

Start date: 2014-06-01
Primary completion: 2018-05-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.